June 17, 2022
Interim study results show 77% treatment response rate among participants.
May 11, 2022
Investigators observed higher levels of depression in children and adolescents with ADHD during MPH treatment.
May 03, 2022
Top-line data for study is expected in late 2022, early 2023.
May 02, 2022
Approval comes 1 year after the drug was approved for the treatment of ADHD in children and adolescents.
April 18, 2022
The warnings cite consumer risks, as well as FD&C, RHA violations.
April 13, 2022
Here are a few reminders to help avoid both toxicity and loss of effectiveness.
April 09, 2022
Research is underway to make psychedelics agents a treatment option for psychiatric disorders.
March 22, 2022
Research also finds surprising results in patients with bipolar affective disorder.
March 22, 2022
Results highlight the impact of education on patient understanding of potential adverse events.
March 04, 2022
Drug comparison has significant implications for dose- and substance-dependence.